These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2167709)
61. Reactivities of antibodies to HIV and SIV in human sera in Kenya, Gabon, and Ghana. Masuda T; Tsujimoto H; Ishikawa K; Ohta Y; Hayami M; Ocheng EM; Johnson BK; Tukei PM; Delaporte E; Cooper RW Lancet; 1988 Feb; 1(8580):297. PubMed ID: 2893105 [No Abstract] [Full Text] [Related]
62. Human immunodeficiency virus: an agent that defies vaccination. Nathanson N; Gonzalez-Scarano F Adv Vet Sci Comp Med; 1989; 33():397-412. PubMed ID: 2648777 [No Abstract] [Full Text] [Related]
64. Prospects for development of a vaccine against HTLV-III-related disorders. Matthews TJ; Lyerly HK; Weinhold KJ; Langlois AJ; Rusche J; Putney SD; Gallo RC; Bolognesi DP AIDS Res Hum Retroviruses; 1987; 3 Suppl 1():197-206. PubMed ID: 2825738 [No Abstract] [Full Text] [Related]
65. HIV: to vaccinate or not to vaccinate? Ada G; Blanden B; Mullbacher A Nature; 1992 Oct; 359(6396):572. PubMed ID: 1406988 [TBL] [Abstract][Full Text] [Related]
66. A reliable animal model for AIDS. Palca J Science; 1990 Jun; 248(4959):1078. PubMed ID: 2160733 [No Abstract] [Full Text] [Related]
67. The quest for vaccines against AIDS: progress and challenges. An overview. Schild GC; Stott EJ Vaccine; 1991 Nov; 9(11):779-81. PubMed ID: 1759497 [No Abstract] [Full Text] [Related]
69. Strategies for the development of vaccines against HIV. Minor PD J Antimicrob Chemother; 1989 Jan; 23 Suppl A():55-62. PubMed ID: 2654115 [TBL] [Abstract][Full Text] [Related]
70. New hope on the AIDS vaccine front. Marx JL Science; 1989 Jun; 244(4910):1254, 1256. PubMed ID: 2734608 [No Abstract] [Full Text] [Related]
71. Choosing the right memory T cell for HIV. Franchini G Nat Med; 2009 Mar; 15(3):244-6. PubMed ID: 19265821 [TBL] [Abstract][Full Text] [Related]
72. No evidence for the contamination of live oral poliomyelitis vaccines with simian immunodeficiency virus. Ohta Y; Tsujimoto H; Ishikawa K; Yamamoto H; Doi Y; Honjo S; Arita M; Hayami M AIDS; 1989 Mar; 3(3):183-5. PubMed ID: 2540773 [No Abstract] [Full Text] [Related]
74. Various approaches to AIDS vaccines begin to 'pierce the armor' of virus. Goldsmith MF JAMA; 1989 Jul; 262(1):13. PubMed ID: 2733115 [No Abstract] [Full Text] [Related]
76. An immunopharmacological approach for prevention of retrovirus-associated disease in human pathology. D'Onofrio C; Bonmassar E Pharmacol Res; 1990; 22(6):645-59. PubMed ID: 1963684 [TBL] [Abstract][Full Text] [Related]
77. Prospects for vaccines against HIV. Zuckerman AJ BMJ; 1988 Jul; 297(6641):86-8. PubMed ID: 3044502 [No Abstract] [Full Text] [Related]
78. Report of a WHO informal consultation on animal models for evaluation of drugs and vaccines for HIV infection and AIDS. W.H.O., Geneva, 14-15 September 1989. Biologicals; 1990 Jul; 18(3):225-33. PubMed ID: 2175206 [TBL] [Abstract][Full Text] [Related]
79. Perspectives on retroviral pathogenesis and vaccines. Weiss RA AIDS Res Hum Retroviruses; 1996 Mar; 12(5):465-7. PubMed ID: 8882335 [No Abstract] [Full Text] [Related]
80. Roundtable: can experience with veterinary retroviral vaccines be applied to the human situation? AIDS Res Hum Retroviruses; 1996 Mar; 12(5):365-73. PubMed ID: 8882312 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]